Eir Ventures Partners AB, a Nordic Life Science Venture Capital manager, has held the final close of its fund Eir Ventures I AB of EUR122.3 million.
Eir Ventures I AB is the firm’s first dedicated life sciences venture capital fund which was launched in 2020 with support from a strong investor syndicate comprising the European Investment Fund (EIF), Novo Holdings, Saminvest, Vækstfonden, as well as a group of prominent Nordic universities, family offices and the founding partners of Eir Ventures.
